vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and New Fortress Energy Inc. (NFE). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $326.2M, roughly 1.5× New Fortress Energy Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -259.7%, a 266.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -7.0%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -26.8%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
MD vs NFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $326.2M |
| Net Profit | $33.7M | $-847.1M |
| Gross Margin | — | 35.5% |
| Operating Margin | 9.9% | -193.0% |
| Net Margin | 6.8% | -259.7% |
| Revenue YoY | -1.7% | -7.0% |
| Net Profit YoY | 10.5% | -277.4% |
| EPS (diluted) | $0.40 | $-3.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $326.2M | ||
| Q3 25 | $492.9M | $240.3M | ||
| Q2 25 | $468.8M | $228.1M | ||
| Q1 25 | $458.4M | $384.9M | ||
| Q4 24 | $502.4M | $350.7M | ||
| Q3 24 | $511.2M | $446.0M | ||
| Q2 24 | $504.3M | $291.2M | ||
| Q1 24 | $495.1M | $609.5M |
| Q4 25 | $33.7M | $-847.1M | ||
| Q3 25 | $71.7M | $-263.0M | ||
| Q2 25 | $39.3M | $-546.5M | ||
| Q1 25 | $20.7M | $-175.4M | ||
| Q4 24 | $30.5M | $-224.4M | ||
| Q3 24 | $19.4M | $9.3M | ||
| Q2 24 | $-153.0M | $-88.9M | ||
| Q1 24 | $4.0M | $54.1M |
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 21.4% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | — | 27.1% | ||
| Q2 24 | — | 23.8% | ||
| Q1 24 | — | 62.4% |
| Q4 25 | 9.9% | -193.0% | ||
| Q3 25 | 13.8% | -37.4% | ||
| Q2 25 | 12.8% | -170.3% | ||
| Q1 25 | 7.0% | -3.3% | ||
| Q4 24 | 7.8% | 65.0% | ||
| Q3 24 | 6.6% | 17.8% | ||
| Q2 24 | -31.3% | 12.3% | ||
| Q1 24 | 3.2% | 30.4% |
| Q4 25 | 6.8% | -259.7% | ||
| Q3 25 | 14.5% | -109.4% | ||
| Q2 25 | 8.4% | -239.6% | ||
| Q1 25 | 4.5% | -45.6% | ||
| Q4 24 | 6.1% | -64.0% | ||
| Q3 24 | 3.8% | 2.1% | ||
| Q2 24 | -30.3% | -30.5% | ||
| Q1 24 | 0.8% | 8.9% |
| Q4 25 | $0.40 | $-3.03 | ||
| Q3 25 | $0.84 | $-0.96 | ||
| Q2 25 | $0.46 | $-1.99 | ||
| Q1 25 | $0.24 | $-0.65 | ||
| Q4 24 | $0.37 | $-1.10 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $-1.84 | $-0.42 | ||
| Q1 24 | $0.05 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $226.5M |
| Total DebtLower is stronger | $570.5M | $8.2B |
| Stockholders' EquityBook value | $865.9M | $182.6M |
| Total Assets | $2.2B | $10.6B |
| Debt / EquityLower = less leverage | 0.66× | 44.78× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $226.5M | ||
| Q3 25 | $340.1M | $145.2M | ||
| Q2 25 | $224.7M | $551.1M | ||
| Q1 25 | $99.0M | $447.9M | ||
| Q4 24 | $229.9M | $492.9M | ||
| Q3 24 | $103.8M | $90.8M | ||
| Q2 24 | $19.4M | $133.0M | ||
| Q1 24 | $8.0M | $143.5M |
| Q4 25 | $570.5M | $8.2B | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $8.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $182.6M | ||
| Q3 25 | $890.7M | $1.1B | ||
| Q2 25 | $833.8M | $1.3B | ||
| Q1 25 | $789.2M | $1.8B | ||
| Q4 24 | $764.9M | $1.9B | ||
| Q3 24 | $732.5M | $1.6B | ||
| Q2 24 | $706.5M | $1.6B | ||
| Q1 24 | $856.2M | $1.7B |
| Q4 25 | $2.2B | $10.6B | ||
| Q3 25 | $2.2B | $12.0B | ||
| Q2 25 | $2.1B | $12.0B | ||
| Q1 25 | $2.0B | $13.1B | ||
| Q4 24 | $2.2B | $12.9B | ||
| Q3 24 | $2.1B | $12.0B | ||
| Q2 24 | $2.0B | $11.4B | ||
| Q1 24 | $2.2B | $10.9B |
| Q4 25 | 0.66× | 44.78× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 4.74× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $-76.2M |
| Free Cash FlowOCF − Capex | — | $-134.8M |
| FCF MarginFCF / Revenue | — | -41.3% |
| Capex IntensityCapex / Revenue | — | 18.0% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $-76.2M | ||
| Q3 25 | $137.3M | $-171.0M | ||
| Q2 25 | $137.2M | $-329.0M | ||
| Q1 25 | $-117.5M | $-7.2M | ||
| Q4 24 | $133.0M | $445.3M | ||
| Q3 24 | $91.8M | $-20.0M | ||
| Q2 24 | $107.0M | $113.9M | ||
| Q1 24 | $-125.2M | $63.0M |
| Q4 25 | — | $-134.8M | ||
| Q3 25 | — | $-231.6M | ||
| Q2 25 | — | $-726.7M | ||
| Q1 25 | — | $-262.3M | ||
| Q4 24 | — | $-210.3M | ||
| Q3 24 | — | $-367.0M | ||
| Q2 24 | — | $-493.2M | ||
| Q1 24 | — | $-457.9M |
| Q4 25 | — | -41.3% | ||
| Q3 25 | — | -96.4% | ||
| Q2 25 | — | -318.6% | ||
| Q1 25 | — | -68.2% | ||
| Q4 24 | — | -60.0% | ||
| Q3 24 | — | -82.3% | ||
| Q2 24 | — | -169.3% | ||
| Q1 24 | — | -75.1% |
| Q4 25 | — | 18.0% | ||
| Q3 25 | — | 25.2% | ||
| Q2 25 | — | 174.4% | ||
| Q1 25 | — | 66.3% | ||
| Q4 24 | — | 187.0% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 208.4% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | -2.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NFE
Segment breakdown not available.
